EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circulating serum microRNAs in kidney transplant recipients with post-transplant malignancies

Roger Bakekolo, Henrietta Gellen, Katalin Gombos, Karoly Kalmár Nagy, Peter Szakaly, Adam Varga

Clinical and Translational Oncology · 07.07.2026

DOI: 10.1007/s12094-026-04501-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Oncology, online erschienen am 07.07.2026. Verfasst von Roger Bakekolo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Medical School, University of Pécs, Ifjúság Street 13, 7624, Pecs, Hungary. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pécsi Tudományegyetem, University of Pécs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Post-transplant malignancies are a major cause of long-term morbidity and mortality in kidney transplant recipients. Reliable non-invasive biomarkers may improve post-transplant oncological surveillance. Circulating microRNAs have emerged as promising candidate biomarkers in several malignancies, but their role in kidney transplant recipients remains poorly characterized.

Objective

To compare circulating serum microRNA concentrations between kidney transplant recipients with and without post-transplant malignancies and to identify candidate microRNAs associated with the presence of malignancy.

Methods

This exploratory pilot study included 40 kidney transplant recipients (27 with post-transplant malignancies and 13 cancer-free controls). Serum concentrations of five preselected microRNAs (miR-21, miR-146a, miR-196a, miR-203a, and miR-221) were quantified using droplet digital PCR. Group comparisons were performed using the Mann–Whitney U test, and receiver operating characteristic (ROC) curve analysis was used to evaluate discriminatory performance.

Results

Serum concentrations of miR-21 and miR-196a were significantly higher in recipients with post-transplant malignancies than in cancer-free controls (both p = 0.003). Serum miR-221 concentrations were also significantly elevated ( p = 0.020), whereas no significant differences were observed for miR-146a or miR-203a. ROC analysis demonstrated acceptable discriminatory performance for miR-21 (AUC 0.742, 95%CI 0.601–0.883) and miR-196a (AUC 0.771, 95%CI 0.619–0.922).

Conclusions

Circulating serum miR-21 and miR-196a were significantly associated with the presence of post-transplant malignancy in kidney transplant recipients, while miR-221 showed an additional exploratory association. These findings support further investigation of circulating microRNAs as candidate non-invasive biomarkers in transplant oncology. Larger prospective studies are required to validate these observations.

Schlagwörter

Stichwörter der Autor:innen

BiomarkerDroplet digital PCRKidney transplantationMicroRNAPost-transplant malignancy

Autor:innen und Institutionen

  • Department of Surgery, Medical School, University of Pécs, Ifjúság Street 13, 7624, Pecs, Hungary.
  • Institute of Laboratory Medicine, Medical School, University of Pécs, Pecs, Hungary.
  • Department of Surgery, Medical School, University of Pécs, Ifjúság Street 13, 7624, Pecs, Hungary. varga.adam@pte.hu.

Förderung

  • Pécsi Tudományegyetem
  • University of Pécs

Zitieren

APA

Bakekolo, R., Gellen, H., Gombos, K., Kalmár Nagy, K., Szakaly, P., & Varga, A. (2026). Circulating serum microRNAs in kidney transplant recipients with post-transplant malignancies. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-026-04501-7

Vancouver

Bakekolo R, Gellen H, Gombos K, Kalmár Nagy K, Szakaly P, Varga A. Circulating serum microRNAs in kidney transplant recipients with post-transplant malignancies. Clinical and Translational Oncology. 2026. doi:10.1007/s12094-026-04501-7

BibTeX
@article{Bakekolo2026,
  author = {Bakekolo, Roger and Gellen, Henrietta and Gombos, Katalin and Kalmár Nagy, Karoly and Szakaly, Peter and Varga, Adam},
  title = {Circulating serum microRNAs in kidney transplant recipients with post-transplant malignancies},
  journal = {Clinical and Translational Oncology},
  year = {2026},
  doi = {10.1007/s12094-026-04501-7}
}
Kostenlos starten →